Curaleaf Holdings (CURLF) Net Income towards Common Stockholders Growth (5y) (2024 - 2026)

Curaleaf Holdings (CURLF) Net Income towards Common Stockholders Growth (5y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.92 Bn	42.96 Bn	-
2	Teva Pharmaceutical Industries	43.19 Bn	39.53 Bn	2.15 Bn
3	Zoetis	31.74 Bn	30.06 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.67 Bn	22.87 Bn	5.10 Bn
5	United Therapeutics	22.22 Bn	19.56 Bn	683.80 Mn
6	Viatris	18.71 Bn	17.83 Bn	1.46 Bn
7	Neurocrine Biosciences	15.55 Bn	15.16 Bn	935.80 Mn
8	Elanco Animal Health	11.80 Bn	11.27 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-
10	Curaleaf Holdings	2.48 Bn	2.38 Bn	169.91 Mn

Download Data